Response to "clarification of enrolled subjects in tolvaptan HF trials". (Record no. 24201503)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01119 a2200337 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516233640.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201501s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1532-6535 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/clpt.2014.191 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Feldman, A M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20150130 |
| 245 00 - TITLE STATEMENT | |
| Title | Response to "clarification of enrolled subjects in tolvaptan HF trials". |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical pharmacology and therapeutics |
| Date of publication, distribution, etc. | Dec 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 661 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Letter; Comment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antidiuretic Hormone Receptor Antagonists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Arginine Vasopressin |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Design |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart Failure |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hamad, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsai, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhu, W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tilley, D G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alvarez, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cheung, J Y |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical pharmacology and therapeutics |
| Related parts | vol. 96 |
| -- | no. 6 |
| -- | p. 661 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/clpt.2014.191">https://doi.org/10.1038/clpt.2014.191</a> |
| Public note | Available from publisher's website |
No items available.